M ycobacterium marinum infection in a case of psoriasis treated with antitumor necrosis factor α antibody detected by Q uanti FERON ® ‐ TB test
2013; Wiley; Volume: 53; Issue: 3 Linguagem: Inglês
10.1111/ijd.12007
ISSN1365-4632
AutoresSakae Kaneko, Mariko Seishima, Yuko Asano, Yuko Chinuki, Eishin Morita,
Tópico(s)Immunodeficiency and Autoimmune Disorders
ResumoInternational Journal of DermatologyVolume 53, Issue 3 p. e187-e189 Correspondence Mycobacterium marinum infection in a case of psoriasis treated with antitumor necrosis factor α antibody detected by QuantiFERON®-TB test Sakae Kaneko MD, Sakae Kaneko MD [email protected] Department of Dermatology, Shimane University Faculty of Medicine, Shimane, JapanSearch for more papers by this authorMariko Seishima MD, Mariko Seishima MD Graduate School of Medicine, Gifu University, Gifu, JapanSearch for more papers by this authorYuko Asano, Yuko Asano Clinical Laboratory, Ogaki Municipal Hospital, Ogaki, JapanSearch for more papers by this authorYuko Chinuki MD, Yuko Chinuki MD Department of Dermatology, Shimane University Faculty of Medicine, Shimane, JapanSearch for more papers by this authorEishin Morita MD, Eishin Morita MD Department of Dermatology, Shimane University Faculty of Medicine, Shimane, JapanSearch for more papers by this author Sakae Kaneko MD, Sakae Kaneko MD [email protected] Department of Dermatology, Shimane University Faculty of Medicine, Shimane, JapanSearch for more papers by this authorMariko Seishima MD, Mariko Seishima MD Graduate School of Medicine, Gifu University, Gifu, JapanSearch for more papers by this authorYuko Asano, Yuko Asano Clinical Laboratory, Ogaki Municipal Hospital, Ogaki, JapanSearch for more papers by this authorYuko Chinuki MD, Yuko Chinuki MD Department of Dermatology, Shimane University Faculty of Medicine, Shimane, JapanSearch for more papers by this authorEishin Morita MD, Eishin Morita MD Department of Dermatology, Shimane University Faculty of Medicine, Shimane, JapanSearch for more papers by this author First published: 15 May 2013 https://doi.org/10.1111/ijd.12007Citations: 6 Conflicts of interest: None declared. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1Salvana EM, Cooper GS, Salata RA. Mycobacterium other than tuberculosis (MOTT) infection: an emerging disease in infliximab-treated patient. J Infect 2007; 55: 484–487. 2Winthrop KL, Chang E, Yamashita S, et al. Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis 2009; 15: 1556–1561. 3Ramos JM, Garcia-Sepulcre MF, Rodrigues JC, et al. Mycobacterium marinum infection complicated by anti-tumour necrosis factor therapy. J Med Microbiol 2010; 59: 617–621. 4Kobashi Y, Mouri K, Obase Y, et al. Clinical evaluation of the QuantiFERON®-TB Gold test in patients with non-tuberculous mycobacterial disease. Int J Tuberc Lung Dis 2009; 13: 1422–1426. 5Andersen P, Munk ME, Pollock JM. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356: 1099–1104. 6Wallis RS. Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. Lancet Infect Dis 2008; 8: 601–611. Citing Literature Volume53, Issue3March 2014Pages e187-e189 ReferencesRelatedInformation
Referência(s)